Endovascular thrombectomy for DAWN- and DEFUSE-3 ineligible acute ischemic stroke patients: a systematic review and meta-analysis.
Endovascular therapy
Ischemic stroke
Large vessel occlusion
Mechanical thrombectomy
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
03 Feb 2024
03 Feb 2024
Historique:
received:
30
11
2023
accepted:
16
01
2024
revised:
11
01
2024
medline:
3
2
2024
pubmed:
3
2
2024
entrez:
2
2
2024
Statut:
aheadofprint
Résumé
Endovascular therapy (EVT) has been proven beneficial for treating acute ischemic strokes (AIS) with large vessel occlusion (LVO). Recent trials of DAWN and DEFUSE-3 have extended the treatment window to 6-24 h, sparking investigations into EVT outcomes for patients not eligible for DAWN/DEFUSE-3 criteria. To assess the outcomes of endovascular therapy (EVT) for late-window anterior circulation large vessel occlusion (LVO) in acute ischemic stroke patients, comparing DAWN/DEFUSE-3 eligible (DD) and ineligible (NDND) groups. This systematic review and meta-analysis examined EVT outcomes for patients with late-window anterior circulation LVO beyond 6 h. We categorized patients as DAWN/DEFUSE-3 eligible (DD) and ineligible (NDND). Our search covered PubMed, Embase, Web of Science, and Scopus. A total of 464 records were initially identified. After duplicate removal, 298 studies were screened. Nine studies were included and analyzed. Our analysis focused on study characteristics, baseline comparisons, risk of bias, and outcomes. Baseline characteristics showed comparable age, gender, most comorbidities, NIHSS score, and ASPECTS between DAWN/DEFUSE-3 eligible (DD) and ineligible (NDND) patients. NDND patients' history showed a higher rate of atrial fibrillation and larger infarct volumes on baseline imaging. Successful reperfusion rates (TICI 2b-3) were similar between DD and NDND with 354 out of 469 in the DD group and 364 out of 459 in the NDND group (OR = 0.86; 95% CI 0.40, 1.84; p = 0.689), though with significant heterogeneity (I This meta-analysis demonstrates equivalent rates of functional independence between DD and NDND patients. However, the high proportion of distal occlusions and higher rates of sICH and mortality in NDND patients suggest caution in offering mechanical thrombectomy to DAWN/DEFUSE-3 ineligible patients. A more flexible approach to EVT eligibility criteria could benefit select patients in real-world practice. Nonetheless, further research is needed to identify which patients would benefit from expanded EVT eligibility criteria.
Sections du résumé
BACKGROUND
BACKGROUND
Endovascular therapy (EVT) has been proven beneficial for treating acute ischemic strokes (AIS) with large vessel occlusion (LVO). Recent trials of DAWN and DEFUSE-3 have extended the treatment window to 6-24 h, sparking investigations into EVT outcomes for patients not eligible for DAWN/DEFUSE-3 criteria.
PURPOSE
OBJECTIVE
To assess the outcomes of endovascular therapy (EVT) for late-window anterior circulation large vessel occlusion (LVO) in acute ischemic stroke patients, comparing DAWN/DEFUSE-3 eligible (DD) and ineligible (NDND) groups.
METHODS
METHODS
This systematic review and meta-analysis examined EVT outcomes for patients with late-window anterior circulation LVO beyond 6 h. We categorized patients as DAWN/DEFUSE-3 eligible (DD) and ineligible (NDND). Our search covered PubMed, Embase, Web of Science, and Scopus. A total of 464 records were initially identified. After duplicate removal, 298 studies were screened. Nine studies were included and analyzed. Our analysis focused on study characteristics, baseline comparisons, risk of bias, and outcomes.
RESULTS
RESULTS
Baseline characteristics showed comparable age, gender, most comorbidities, NIHSS score, and ASPECTS between DAWN/DEFUSE-3 eligible (DD) and ineligible (NDND) patients. NDND patients' history showed a higher rate of atrial fibrillation and larger infarct volumes on baseline imaging. Successful reperfusion rates (TICI 2b-3) were similar between DD and NDND with 354 out of 469 in the DD group and 364 out of 459 in the NDND group (OR = 0.86; 95% CI 0.40, 1.84; p = 0.689), though with significant heterogeneity (I
CONCLUSION
CONCLUSIONS
This meta-analysis demonstrates equivalent rates of functional independence between DD and NDND patients. However, the high proportion of distal occlusions and higher rates of sICH and mortality in NDND patients suggest caution in offering mechanical thrombectomy to DAWN/DEFUSE-3 ineligible patients. A more flexible approach to EVT eligibility criteria could benefit select patients in real-world practice. Nonetheless, further research is needed to identify which patients would benefit from expanded EVT eligibility criteria.
Identifiants
pubmed: 38308162
doi: 10.1007/s00415-024-12198-3
pii: 10.1007/s00415-024-12198-3
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Références
Jovin TG, Li C, Wu L, Wu C, Chen J, Jiang C et al (2022) Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion. N Engl J Med 387(15):1373–1384
doi: 10.1056/NEJMoa2207576
pubmed: 36239645
Tao C, Nogueira RG, Zhu Y, Sun J, Han H, Yuan G et al (2022) Trial of endovascular treatment of acute basilar-artery occlusion. N Engl J Med 387(15):1361–1372
doi: 10.1056/NEJMoa2206317
pubmed: 36239644
Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N et al (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372(11):1009–1018
doi: 10.1056/NEJMoa1414792
pubmed: 25671797
Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A et al (2015) Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 372(24):2296–2306
doi: 10.1056/NEJMoa1503780
pubmed: 25882510
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J et al (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372(11):1019–1030
doi: 10.1056/NEJMoa1414905
pubmed: 25671798
Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM et al (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372(24):2285–2295
doi: 10.1056/NEJMoa1415061
pubmed: 25882376
Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ et al (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372(1):11–20
doi: 10.1056/NEJMoa1411587
pubmed: 25517348
Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S et al (2018) Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 378(8):708–718
doi: 10.1056/NEJMoa1713973
pubmed: 29364767
pmcid: 6590673
Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P et al (2018) Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 378(1):11–21
doi: 10.1056/NEJMoa1706442
pubmed: 29129157
Dittrich TD, Sporns PB, Kriemler LF, Rudin S, Nguyen A, Zietz A et al (2023) Mechanical thrombectomy for large vessel occlusion between 6 and 24 h: outcome comparison of DEFUSE-3/DAWN eligible versus non-eligible patients. Int J Stroke 18(6):697–703
doi: 10.1177/17474930221140793
pubmed: 36367319
Virtanen P, Tomppo L, Martinez-Majander N, Kokkonen T, Sillanpaa M, Lappalainen K et al (2022) Thrombectomy in acute ischemic stroke in the extended time window: real-life experience in a high-volume center. J Stroke Cerebrovasc Dis 31(8):106603
doi: 10.1016/j.jstrokecerebrovasdis.2022.106603
pubmed: 35749938
Siegler JE, Messe SR, Sucharew H, Kasner SE, Mehta T, Arora N et al (2020) Thrombectomy in DAWN- and DEFUSE-3-ineligible patients: a subgroup analysis from the best prospective cohort study. Neurosurgery 86(2):E156–E163
doi: 10.1093/neuros/nyz485
pubmed: 31758197
Desai SM, Rocha M, Molyneaux BJ, Starr M, Kenmuir CL, Gross BA et al (2018) Thrombectomy 6–24 hours after stroke in trial ineligible patients. J Neurointerv Surg 10(11):1033–1037
doi: 10.1136/neurintsurg-2018-013915
pubmed: 29773716
Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ et al (2019) Cochrane handbook for systematic reviews of interventions. Wiley, New York
doi: 10.1002/9781119536604
Herzberg M, Scherling K, Stahl R, Tiedt S, Wollenweber FA, Kupper C et al (2021) Late Thrombectomy in clinical practice : retrospective application of DAWN/DEFUSE3 criteria within the German stroke registry. Clin Neuroradiol 31(3):799–810
doi: 10.1007/s00062-021-01033-1
pubmed: 34097080
pmcid: 8463374
Morsi RZ, Elfil M, Ghaith HS, Aladawi M, Elmashad A, Kothari S et al (2023) endovascular thrombectomy for large ischemic strokes: a living systematic review and meta-analysis of randomized trials. J Stroke 25(2):214–222
doi: 10.5853/jos.2023.00752
pubmed: 37282371
pmcid: 10250873
Ducroux C, Khoury N, Lecler A, Blanc R, Chetrit A, Redjem H et al (2018) Application of the DAWN clinical imaging mismatch and DEFUSE 3 selection criteria: benefit seems similar but restrictive volume cut-offs might omit potential responders. Eur J Neurol 25(8):1093–1099
doi: 10.1111/ene.13660
pubmed: 29667266
de Havenon A, Mickolio K, O’Donnell S, Stoddard G, McNally JS, Alexander M et al (2021) Predicting neuroimaging eligibility for extended-window endovascular thrombectomy. J Neurosurg 135(4):1100–1104
pubmed: 33636705
pmcid: 8387497
Nannoni S, Strambo D, Sirimarco G, Amiguet M, Vanacker P, Eskandari A et al (2020) Eligibility for late endovascular treatment using DAWN, DEFUSE-3, and more liberal selection criteria in a stroke center. J Neurointerv Surg 12(9):842–847
doi: 10.1136/neurintsurg-2019-015382
pubmed: 31772044
Gao L, Bivard A, Parsons M, Spratt NJ, Levi C, Butcher K et al (2021) Real-world cost-effectiveness of late time window thrombectomy for patients with ischemic stroke. Front Neurol 12:780894
doi: 10.3389/fneur.2021.780894
pubmed: 34970213
pmcid: 8712752
Charbonnier G, Bonnet L, Biondi A, Moulin T (2020) Intracranial bleeding after reperfusion therapy in acute ischemic stroke. Front Neurol 11:629920
doi: 10.3389/fneur.2020.629920
pubmed: 33633661
Hao Y, Zhang Z, Zhang H, Xu L, Ye Z, Dai Q et al (2017) Risk of intracranial hemorrhage after endovascular treatment for acute ischemic stroke: systematic review and meta-analysis. Interv Neurol 6(1–2):57–64
doi: 10.1159/000454721
pubmed: 28611835
pmcid: 5465656
Ni H, Lu GD, Hang Y, Jia ZY, Cao YZ, Shi HB et al (2023) Association between infarct location and hemorrhagic transformation of acute ischemic stroke following successful recanalization after mechanical thrombectomy. AJNR Am J Neuroradiol 44(1):54–59
doi: 10.3174/ajnr.A7742
pubmed: 36521961
pmcid: 9835909
Meinel TR, Kniepert JU, Seiffge DJ, Gralla J, Jung S, Auer E et al (2020) Endovascular stroke treatment and risk of intracranial hemorrhage in anticoagulated patients. Stroke 51(3):892–898
doi: 10.1161/STROKEAHA.119.026606
pubmed: 31992179
Kobeissi H, Ghozy S, Seymour T, Gupta R, Bilgin C, Kadirvel R et al (2023) Outcomes of patients with atrial fibrillation following thrombectomy for stroke: a systematic review and meta-analysis. JAMA Netw Open 6(1):e2249993
doi: 10.1001/jamanetworkopen.2022.49993
pubmed: 36607633
pmcid: 9857225